Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
49,594,356
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
4,239,917
-
Shares change
-
-90,817
-
Total reported value, excl. options
-
$6,914,602
-
Value change
-
-$572,034
-
Put/Call ratio
-
11%
-
Number of buys
-
21
-
Number of sells
-
25
-
Price
-
$1.63
Institutional Holders of PDS Biotechnology Corp - Common (PDSB) as of Q4 2024
As of 31 Dec 2024 PDS Biotechnology Corp - Common (PDSB) had 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 4,239,917 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., GEODE CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, BLAIR WILLIAM & CO/IL, STATE STREET CORP, MILLENNIUM MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, and NORTHERN TRUST CORP.
This table shows 51 institutional shareholders of the security as of 31 Dec 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.